MPO and asthma: Interestingly, patients with mild asthma and rhinovirus infection that received mepolizumab treatment displayed a lower increase of neutrophils and neutrophil-derived myeloperoxidase in both BALF and sputum but also an increment of B lymphocytes and secretory IgA (Sabogal Piñeros et al., 2019b).